Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/C9A_OlIa6gE/246011.php
news Massage St Albans">auto sport medical
Thursday 31 May 2012
MabThera Confirmed As Beneficial For Treating Non-Hodgkin's Lymphoma
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded, after conducting a quality review of the genetically engineered monoclonal antibody MabThera, that the batches of rituximab, the active substance of MabThera, that were produced in the U.S. at the Vacaville manufacturing site do not present a risk to public health...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment